Login / Signup

Understanding Drug Repurposing From the Perspective of Biomedical Entities and Their Evolution: Bibliographic Research Using Aspirin.

Xin LiJustin F RousseauYing DingMin SongWei Lu
Published in: JMIR medical informatics (2020)
In-depth studies of side effects and mechanisms, fierce market competition, and advanced life science technologies are driving factors for DR. This study showcases the way in which researchers can examine the evolution of DR using entitymetrics, an approach that can be valuable for enhancing decision making in the field of drug discovery and development.
Keyphrases
  • drug discovery
  • editorial comment
  • low dose
  • public health
  • optical coherence tomography
  • type diabetes
  • case control
  • acute coronary syndrome
  • anti inflammatory drugs